(Q39789185)

14 September 2017

title

Establishment of shared antigen reactive cytotoxic T lymphocyte using co-stimulatory molecule introduced autologous cancer cells (English)

1 reference

14 September 2017

0 references

0 references

2

Toshihiko Torigoe

1 reference

14 September 2017

1

Yoshihiko Hirohashi

1 reference

14 September 2017

12

Noriyuki Sato

1 reference

14 September 2017

4

Yasuaki Tamura

1 reference

14 September 2017

7

Takayuki Kanaseki

1 reference

14 September 2017

8

Kenjiro Kamiguchi

1 reference

14 September 2017

5

Munehide Nakatsugawa

1 reference

14 September 2017

9

Hideyuki Ikeda

1 reference

14 September 2017

3

Itaru Hirai

1 reference

14 September 2017

11

Noboru Yamanaka

1 reference

14 September 2017

Yuuji Inoue

6

1 reference

14 September 2017

Aya Sasaki

series ordinal

10

1 reference

14 September 2017

publication date

8 October 2009

1 reference

Experimental and Molecular Pathology

14 September 2017

published in

1 reference

14 September 2017

volume

88

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

128-132

1 reference

describes a project that uses

14 September 2017

0 references

0 references

0 references

0 references

Tumor antigens recognized by T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.021

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.021

Adenoviral delivery of B7-1 (CD80) increases the immunogenicity of human ovarian and cervical carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.021

The functioning antigens: beyond just as the immunological targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.021

Analysis of a Shared Pancreatic Cancer Antigen Recognized by an HLA-A*2601-Restricted Cytotoxic T-Lymphocyte Clone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.021

Expression of CD80 enhances immunogenicity of cervical carcinoma cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.021

Clonal diversity of cytotoxic T lymphocytes that recognize autologous oral squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.021

Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.021

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.021

Cytotoxicity of histocompatibility leukocyte antigen-DR8-restricted CD4 killer T cells against human autologous squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.021

Effect of B7.1-transfected human colon cancer cells on the induction of autologous tumour-specific cytotoxic T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.021

Recognition by cellular and humoral autologous immunity in a human osteosarcoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.021

A new era for cancer immunotherapy based on the genes that encode cancer antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.021

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.021

A cell culture model for T lymphocyte clonal anergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.021

Successful induction of tumor-specific cytotoxic T lymphocytes from patients with non-small cell lung cancer using CD80-transfected autologous tumor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.021

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.021

T-cell receptor gene structures of HLA-A26-restricted cytotoxic T lymphocyte lines against human autologous pancreatic adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.021

Characterization of human non-small cell lung cancer (NSCLC) cell lines for expression of MHC, co-stimulatory molecules and tumor-associated antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.021

The mechanism of human autologous gastric signet ring cell tumor rejection by cytotoxic T lymphocytes in the possible context of HLA-A31 molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.021

10.1016/J.YEXMP.2009.09.021

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference